文献速递乳腺癌

EUSOMA非转移性乳腺癌质量指标:更新版

EUSOMA quality indicators for non-metastatic breast cancer: An update.
PubMed 文献 · Eur J Cancer · 2023-12-26

EUSOMA基于新的诊断、局部区域和全身治疗模式,更新了2017年非转移性乳腺癌质量指标,由多学科专家组和患者代表共同制定,首次纳入患者报告结局指标,将质量指标分为强制性、推荐性和观察性三类,并设定最低标准和目标值。

要点

  • EUSOMA更新非转移性乳腺癌质量指标,涵盖诊断、局部区域和全身治疗各环节。
  • 质量指标分为强制性、推荐性和观察性三类,并设最低标准和目标值。
  • 首次纳入患者报告结局指标(PROMs)。

核心结论

  • 监测这些质量指标并在EUSOMA数据中心内实施,将有助于呈现欧洲乳腺中心的最新水平并推动具有挑战性的研究项目。

研究设计与样本

  • EUSOMA成立了一个由乳腺癌专家和患者代表组成的多学科工作组,对2017年非转移性乳腺癌质量指标进行更新。
  • 证据等级基于美国医疗保健研究与质量局(AHRQ)的简版分级系统。

主要发现

  • 该质量指标集覆盖非转移性乳腺癌患者诊疗路径的不同环节,使乳腺中心能够以参考标准(即最低标准和目标值)监测其表现。
  • 质量指标被分类为强制性、推荐性或观察性。
  • 首次纳入了患者报告结局指标(PROMs)。

关键数值与推荐

  • 质量指标分为强制性、推荐性和观察性三类,并设有最低标准和目标值。
  • 证据等级基于美国医疗保健研究与质量局(AHRQ)的简版分级系统。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Quality care in breast cancer is higher if patients are treated in a Breast Center with a dedicated and specialized multidisciplinary team. Quality control is an essential activity to ensure quality care, which has to be based on the monitoring of specific quality indicators. Eusoma has proceeded with the up-dating of the 2017 Quality indicators for non-metastatic breast cancer based on the new diagnostic, locoregional and systemic treatment modalities. METHODS: To proceed with the updating, EUSOMA setup a multidisciplinary working group of BC experts and patients' representatives. It is a comprehensive set of QIs for early breast cancer care, which are classified as mandatory, recommended, or observational. For the first time patient reported outcomes (PROMs) have been included. As used in the 2017 EUSOMA QIs, evidence levels were based on the short version of the US Agency for Healthcare Research and Quality. RESULTS: This is a set of quality indicators representative for the different steps of the patient pathway in non-metastatic setting, which allow Breast Centres to monitor their performance with referring standards, i.e minimum standard and target. CONCLUSIONS: Monitoring these Quality Indicators, within the Eusoma datacentre will allow to have a state of the art picture at European Breast Centres level and the development of challenging research projects.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Rubio IT, Marotti L, Biganzoli L, et al. EUSOMA quality indicators for non-metastatic breast cancer: An update. Eur J Cancer. 2023. PMID: 38199146. doi:10.1016/j.ejca.2023.113500

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。